| ADTX 0.007 -35.78% | AZTR 0.2329 26.51% | GDC 0.0243 -13.52% | SOXS 4.17 -9.94% | SNBR 0.3712 110.19% | GPUS 0.3457 32.96% | YMAT 0.7155 85.36% | SRXH 0.2475 30.26% | OBAI 1.271 14.50% | SPCX 195.55 -3.10% | VIVK 0.5844 10.47% | CIIT 0.6266 41.76% | TZA 4.1002 -1.67% | NIVF 0.9484 35.49% | BITO 8.87 -0.56% | NOK 13.845 -0.97% | INTC 120.78 3.19% | NEOV 1.9372 13.29% | WOK 0.043 -15.19% | NVDA 207.525 0.06% | SNAP 4.8902 -5.14% | LNAI 4.1483 45.81% | GNS 0.225 4.80% | TQQQ 81.235 1.63% | SOFI 18.42 4.01% | PAVS 0.174 -9.84% | SQQQ 37.745 -1.58% | RXT 7.43 19.65% | UTSI 2.81 -5.07% | TSLL 13.2386 -1.57% | SOXL 247.91 9.60% | PLUG 2.86 5.54% | NU 13.37 5.11% | COSM 0.2558 2.40% | EOSE 7.47 9.69% | YYGH 0.1285 -8.87% | BURU 0.1496 1.77% | SMR 10.35 4.65% | T 22.505 -2.83% | MU 1038.39 1.73% | MRVL 292.56 4.98% | DRIP 5.29 1.44% | ELTX 3.2 15.94% | KEEL 6.205 4.11% | NVD 4.8901 0.00% | ONDS 9.195 -0.16% | MCRP 2.245 7.93% | AMC 2.615 5.02% | NFLX 78.005 -0.91% | AAL 15.81 0.64%

Anheuser-Busch InBev SA/NV (BUD) Stock Performance and Growth Prospects

Anheuser-Busch InBev SA/NV, known by its stock symbol NYSE:BUD, is a leading global brewer. The company is renowned for its extensive portfolio of over 500 beer brands, including Budweiser, Stella Artois, and Corona. As a dominant player in the beverage industry, BUD competes with other major brewers like Heineken and Molson Coors.

BUD has recently caught the attention of investors due to its promising stock performance. Over the past month, the stock has gained approximately 5.77%, reflecting strong investor confidence and positive market sentiment. This upward trend suggests that BUD is on a growth trajectory, making it an attractive option for those seeking investment opportunities.

Despite a minor setback in the past 10 days, with a loss of about 2.86%, BUD's overall performance remains strong. This recent dip could be seen as a buying opportunity for investors who believe in the stock's potential to rebound. The stock's growth potential is further underscored by its estimated 12.66% price appreciation, indicating that it may be undervalued.

BUD's financial health is robust, as evidenced by its Piotroski Score of 8. This score highlights the company's financial stability and operational efficiency, making it a reliable choice for investors. Analysts have set a target price of $86.33 for BUD, aligning with its growth prospects and financial strength.

Published on: March 3, 2026